LUPIN LIMITED
Patent Owner
Stats
- 72 US PATENTS IN FORCE
- 15 US APPLICATIONS PENDING
- Feb 06, 2018 most recent publication
Details
- 72 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 569 Total Citation Count
- May 25, 2000 Earliest Filing
- 93 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0259,241 A MANUFACTURING PROCESS FOR AN IRON CONTAINING ADSORBENTSep 09, 15Sep 14, 17[A61K, B01J]
2017/0218,007 A PROCESS FOR THE PREPARATION OF NUCLEOSIDE PHOSPHORAMIDATEJul 31, 15Aug 03, 17[C07H, C07F]
2016/0287,614 Stable Pharmaceutical Formulation(s) of Tetracycline AntibioticNov 19, 14Oct 06, 16[A61K, A61Q]
2016/0015,698 PHARMACEUTICAL COMPOSITIONS OF DONEPEZIL HAVING SPECIFIC IN VITRO DISSOLUTION PROFILE OR PHARMACOKINETICS PARAMETERSFeb 27, 14Jan 21, 16[A61K]
2014/0315,871 TOPICAL PHARMACEUTICAL COMPOSITIONS OF ANTI-MICROBIAL AGENTS AND ANTI-INFLAMMATORY AGENTSDec 07, 12Oct 23, 14[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9884022 Controlled release pharmaceutical compositions of tapentadolFeb 07, 11Feb 06, 18[A61K, C07C, A61P]
9820936 Oral controlled release pharmaceutical compositions of BepotastineJul 12, 16Nov 21, 17[A61K]
9790231 Chromane and chromene derivatives and their use as CRAC modulatorsJun 23, 14Oct 17, 17[A61K, C07D]
9737534 Oxazoline and isoxazoline derivatives as CRAC modulatorsAug 31, 15Aug 22, 17[A61K, C07D, A61P]
9670262 Modified SAK gene for the production of recombinant proteinsAug 28, 14Jun 06, 17[C07H, A61K, C12P, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0137,415 SULFONAMIDE COMPOUNDS AS VOLTAGE GATED SODIUM CHANNEL MODULATORSAbandonedMar 27, 15May 18, 17[C07D]
2015/0299,178 Thiazole Derivatives as Alpha 7 NACHR ModulatorsAbandonedNov 11, 13Oct 22, 15[A61K, C07D]
2015/0283,252 STABLE PHARMACEUTICAL COMPOSITION OF PEGINTERFERON ALPHA-2BAbandonedOct 25, 13Oct 08, 15[A61K]
2015/0274,770 NOVEL PROCESS AND INTERMEDIATE FOR PREPARATION OF ULIPRISTALAbandonedOct 01, 13Oct 01, 15[C07J]
2015/0225,380 Novel Method to Obtain Olmesartan Medoxomil With Reduced Particle SizeAbandonedJul 26, 13Aug 13, 15[C07D]
2015/0209,432 PHARMACEUTICAL COMPOSITIONS OF PROTON PUMP INHIBITORAbandonedJul 22, 13Jul 30, 15[A61K]
2014/0323,758 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATEAbandonedNov 16, 12Oct 30, 14[C07C]
2014/0171,401 NOVEL PHARMACEUTICAL FORMULATION OF CEFIXIME FOR ENHANCED BIOAVAILABILITYAbandonedFeb 24, 14Jun 19, 14[A61K]
2014/0010,883 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORAbandonedMar 16, 12Jan 09, 14[A61K]
2013/0310,419 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHRAbandonedJan 31, 12Nov 21, 13[A61K, C07D]
2013/0296,562 STEREOSELECTIVE PROCESS FOR PREPARATION OF 1,3-OXATHIOLANE NUCLEOSIDESAbandonedJan 10, 12Nov 07, 13[C07D]
2013/0225,845 PROCESS FOR PREPARATION OF ESTRADIOL VALERATE AND A NOVEL CRYSTALLINE FORM A OF ESTRADIOL DIVALERATEAbandonedOct 28, 11Aug 29, 13[C07J]
2013/0203,721 TASTE-MASKED POWDER FOR SUSPENSION COMPOSITIONS OF METHYLPREDNISOLONEAbandonedFeb 22, 11Aug 08, 13[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.